How much is the Neurodiagnostic and Monitoring Devices market?

The neurodiagnostic and monitoring devices market size is estimated to grow at $827.88 million in 2023. Read More

What is the growth rate of the Neurodiagnostic and Monitoring Devices market?

The growth rate of the neurodiagnostic and monitoring devices year-over-year is 6.19%. Read More

Which region held the largest market share in the Neurodiagnostic and Monitoring Devices market?

North America is the region to held the largest market share with 100% growth. Read More

Who are the key players in the Neurodiagnostic and Monitoring Devices market?

Advanced Brain Monitoring Inc., Ambu AS, Bio Signal Group Corp., Cadwell Industries Inc., Compumedics Ltd., Delsys Inc., ELMIKO BIOSIGNALS sp. z o.o., General Electric .... Read More

Which Segment has the largest market share in the Neurodiagnostic and Monitoring Devices market?

Product is the segment that has the largest market share in the market. Read More

US - Neurodiagnostic and Monitoring Devices Market by Product, End-user, and Application - Forecast and Analysis 2024-2028

Published: Oct 2023
Pages: 165
SKU: IRTNTR40602

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Country Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 08: Parent market
- Exhibit 09: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 10: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 11: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
- Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Neurodiagnostic and monitoring devices market in US 2018 - 2022
- Exhibit 16: Historic Market Size – Data Table on neurodiagnostic and monitoring devices market in US 2018 - 2022 ($ million)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 17: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 18: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 20: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 21: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 22: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 23: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 24: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 25: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 27: Chart on Product - Market share 2023-2028 (%)
- Exhibit 28: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 29: Chart on Comparison by Product
- Exhibit 30: Data Table on Comparison by Product

6.3 ICP Monitoring devices - Market size and forecast 2023-2028
- Exhibit 31: Chart on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 32: Data Table on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 33: Chart on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)
- Exhibit 34: Data Table on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)

6.4 EEG devices - Market size and forecast 2023-2028
- Exhibit 35: Chart on EEG devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Data Table on EEG devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 37: Chart on EEG devices - Year-over-year growth 2023-2028 (%)
- Exhibit 38: Data Table on EEG devices - Year-over-year growth 2023-2028 (%)

6.5 EMG devices - Market size and forecast 2023-2028
- Exhibit 39: Chart on EMG devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Data Table on EMG devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 41: Chart on EMG devices - Year-over-year growth 2023-2028 (%)
- Exhibit 42: Data Table on EMG devices - Year-over-year growth 2023-2028 (%)

6.6 Others - Market size and forecast 2023-2028
- Exhibit 43: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 45: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 46: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.7 Market opportunity by Product
- Exhibit 47: Market opportunity by Product ($ million)
- Exhibit 48: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 49: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 50: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 51: Chart on Comparison by End-user
- Exhibit 52: Data Table on Comparison by End-user

7.3 Hospitals - Market size and forecast 2023-2028
- Exhibit 53: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 55: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 56: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

7.4 Clinics - Market size and forecast 2023-2028
- Exhibit 57: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 59: Chart on Clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 60: Data Table on Clinics - Year-over-year growth 2023-2028 (%)

7.5 Laboratories - Market size and forecast 2023-2028
- Exhibit 61: Chart on Laboratories - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Data Table on Laboratories - Market size and forecast 2023-2028 ($ million)
- Exhibit 63: Chart on Laboratories - Year-over-year growth 2023-2028 (%)
- Exhibit 64: Data Table on Laboratories - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 65: Market opportunity by End-user ($ million)
- Exhibit 66: Data Table on Market opportunity by End-user ($ million)

8 Market Segmentation by Application

8.1 Market segments
- Exhibit 67: Chart on Application - Market share 2023-2028 (%)
- Exhibit 68: Data Table on Application - Market share 2023-2028 (%)

8.2 Comparison by Application
- Exhibit 69: Chart on Comparison by Application
- Exhibit 70: Data Table on Comparison by Application

8.3 Stroke - Market size and forecast 2023-2028
- Exhibit 71: Chart on Stroke - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Stroke - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Stroke - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Stroke - Year-over-year growth 2023-2028 (%)

8.4 Migraine - Market size and forecast 2023-2028
- Exhibit 75: Chart on Migraine - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Migraine - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Migraine - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Migraine - Year-over-year growth 2023-2028 (%)

8.5 Epilepsy - Market size and forecast 2023-2028
- Exhibit 79: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)

8.6 Parkinsons disease - Market size and forecast 2023-2028
- Exhibit 83: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)

8.7 Ischemic stroke - Market size and forecast 2023-2028
- Exhibit 87: Chart on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Ischemic stroke - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Ischemic stroke - Year-over-year growth 2023-2028 (%)

8.8 Market opportunity by Application
- Exhibit 91: Market opportunity by Application ($ million)
- Exhibit 92: Data Table on Market opportunity by Application ($ million)

9 Customer Landscape

9.1 Customer landscape overview
- Exhibit 93: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 94: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 95: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 96: Overview on factors of disruption

11.4 Industry risks
- Exhibit 97: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 98: Vendors covered

12.2 Market positioning of vendors
- Exhibit 99: Matrix on vendor position and classification

12.3 Advanced Brain Monitoring Inc.
- Exhibit 100: Advanced Brain Monitoring Inc. - Overview
- Exhibit 101: Advanced Brain Monitoring Inc. - Key offerings

12.4 Ambu AS
- Exhibit 102: Ambu AS - Overview
- Exhibit 103: Ambu AS - Business segments
- Exhibit 104: Ambu AS - Key offerings
- Exhibit 105: Ambu AS - Segment focus

12.5 Bio Signal Group Corp.
- Exhibit 106: Bio Signal Group Corp. - Overview
- Exhibit 107: Bio Signal Group Corp. - Product / Service
- Exhibit 108: Bio Signal Group Corp. - Key offerings

12.6 Cadwell Industries Inc.
- Exhibit 109: Cadwell Industries Inc. - Overview
- Exhibit 110: Cadwell Industries Inc. - Product / Service
- Exhibit 111: Cadwell Industries Inc. - Key offerings

12.7 Compumedics Ltd.
- Exhibit 112: Compumedics Ltd. - Overview
- Exhibit 113: Compumedics Ltd. - Product / Service
- Exhibit 114: Compumedics Ltd. - Key offerings

12.8 Delsys Inc.
- Exhibit 115: Delsys Inc. - Overview
- Exhibit 116: Delsys Inc. - Product / Service
- Exhibit 117: Delsys Inc. - Key offerings

12.9 ELMIKO BIOSIGNALS sp. z o.o.
- Exhibit 118: ELMIKO BIOSIGNALS sp. z o.o. - Overview
- Exhibit 119: ELMIKO BIOSIGNALS sp. z o.o. - Product / Service
- Exhibit 120: ELMIKO BIOSIGNALS sp. z o.o. - Key offerings

12.10 General Electric Co.
- Exhibit 121: General Electric Co. - Overview
- Exhibit 122: General Electric Co. - Business segments
- Exhibit 123: General Electric Co. - Key news
- Exhibit 124: General Electric Co. - Key offerings
- Exhibit 125: General Electric Co. - Segment focus

12.11 Koninklijke Philips N.V.
- Exhibit 126: Koninklijke Philips N.V. - Overview
- Exhibit 127: Koninklijke Philips N.V. - Business segments
- Exhibit 128: Koninklijke Philips N.V. - Key news
- Exhibit 129: Koninklijke Philips N.V. - Key offerings
- Exhibit 130: Koninklijke Philips N.V. - Segment focus

12.12 Lifelines Neuro Company LLC
- Exhibit 131: Lifelines Neuro Company LLC - Overview
- Exhibit 132: Lifelines Neuro Company LLC - Product / Service
- Exhibit 133: Lifelines Neuro Company LLC - Key offerings

12.13 Masimo Corp.
- Exhibit 134: Masimo Corp. - Overview
- Exhibit 135: Masimo Corp. - Product / Service
- Exhibit 136: Masimo Corp. - Key offerings

12.14 Medtronic Plc
- Exhibit 137: Medtronic Plc - Overview
- Exhibit 138: Medtronic Plc - Business segments
- Exhibit 139: Medtronic Plc - Key news
- Exhibit 140: Medtronic Plc - Key offerings
- Exhibit 141: Medtronic Plc - Segment focus

12.15 Natus Medical Inc.
- Exhibit 142: Natus Medical Inc. - Overview
- Exhibit 143: Natus Medical Inc. - Product / Service
- Exhibit 144: Natus Medical Inc. - Key news
- Exhibit 145: Natus Medical Inc. - Key offerings

12.16 Nihon Kohden Corp.
- Exhibit 146: Nihon Kohden Corp. - Overview
- Exhibit 147: Nihon Kohden Corp. - Product / Service
- Exhibit 148: Nihon Kohden Corp. - Key news
- Exhibit 149: Nihon Kohden Corp. - Key offerings

12.17 Viasonix Ltd
- Exhibit 150: Viasonix Ltd - Overview
- Exhibit 151: Viasonix Ltd - Product / Service
- Exhibit 152: Viasonix Ltd - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 153: Inclusions checklist
- Exhibit 154: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 155: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 156: Research methodology
- Exhibit 157: Validation techniques employed for market sizing
- Exhibit 158: Information sources

13.5 List of abbreviations
- Exhibit 159: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES